The cluster is small relative to market cap but broad-based across C-suite and board. With no 10b5-1 pattern and no offsetting buys, this is a modestly bearish signal. Monitor for upcoming earnings, pipeline updates (PHVS is a clinical-stage biotech), or a material agreement that may have prompted the selling. If a catalyst like data readout or financing is imminent, the selling could be informed, but at current scale, it does not warrant immediate action.
PHVS drugs
PHVS drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 27 $29.47entry
- T+1 · 6mo ago +1.32%α +0.77% · $29.86
- T+5 · 6mo ago +2.27%α +1.80% · $30.14
- T+20 · 5mo ago +13.00%α +14.90% · $33.30
- T+60 · 3mo ago +23.48%α +21.60% · $36.39
Price Chart
How similar events traded
Executive Summary
Six Pharvaris insiders, including the CEO, CFO, and CCO, sold a total of $1.38M in stock over a 7-day window. The cluster is 100% open-market sales with no offsetting purchases, and the CEO's sale is notable for its timing. At $2.1B market cap, the total represents ~0.07%, below the 0.1% materiality threshold, but the breadth of C-suite participation and the absence of any 10b5-1 pattern elevate the signal. The cross-filing actuarial verdicts show this cluster-insider-trades pattern is an AMPLIFIER when combined with other contexts, but no other material cross-filings (earnings, offering, restatement) are present in the provided context to trigger an override.
Key Financial Metrics
Key Facts
- Six insiders sold a total of $1.38M in open-market sales over 7 days (May 14–21, 2026).
- CEO Berndt Modig sold 2,300 shares at $29.22 for $67K, his first sale in the cluster window.
- CFO/CLO David Nassif sold 10,000 shares at $30.31 for $303K on May 21, the largest single trade.
- Director Elisabeth Bjork sold 10,000 shares at $29.32 for $293K on May 20, following derivative exercises.
- CCO Wim Souverijns sold 10,000 shares at $29.92 for $299K on May 15.
- Total cluster value of $1.38M is ~0.07% of Pharvaris's $2.1B market cap, below the 0.1% materiality threshold.
- No 10b5-1 plan disclosures or regular pattern in sale sizes/dates to suggest routine liquidity-driven sales.
- All six insiders sold; zero insider purchases in the cluster window.
Financial Impact
Total insider sales of $1.38M represent ~0.07% of Pharvaris's $2.1B market cap, below the 0.1% materiality threshold for a standalone cluster, but the breadth of C-suite participation (CEO, CFO, CCO) and lack of purchases is notable.
Risk Factors
- Insider selling may signal lack of confidence ahead of a catalyst (e.g., clinical trial readout, regulatory update).
- No offsetting purchases, all six insiders sold, creating a uniform bearish signal.
- CEO sale, though small, is the first in the cluster window and could be informational.
- Clinical-stage biotech risk: any negative pipeline news could amplify the selling signal ex post.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1779831760828 |
Track record
51 reports on PHVS
15 of 17 bullish or bearish reports moved the stock their way by T+5. Best: +23.73% at T+20 after the Sep 17, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $33.19 Now $32.44 −2.26% settles Nov 23
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $33.59 Now $32.44 +3.42% settles Nov 23
- Nov 12, 20264d ago Press Release Bullish 7/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Nov 12, 20264d ago 6-K Neutral 4/10 No price data
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $33.83 Now $32.44 −4.11% settles Nov 19
- Sep 25, 20267w ago Insider Cluster Bearish 6/10 Entry $32.02 to $31.19 Now $32.44 −1.31% ▲ +2.59% +2.37% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 7/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 24, 20267w ago Insider Cluster Bearish 5/10 Entry $32.99 to $31.01 Now $32.44 +1.67% ▲ +6.00% +5.59% vs SPY
- Sep 23, 20267w ago Insider Cluster Bearish 6/10 Entry $33.07 to $31.72 Now $32.44 +1.91% ▲ +4.08% +3.41% vs SPY
- Sep 21, 20268w ago Insider Cluster Bearish 5/10 Entry $36.02 to $31.91 Now $32.44 +9.94% ▲ +11.41% +10.39% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers